Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Ou

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Structure (London, England : 1993)|March 17, 2023
Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitopePrabhanshu Tripathi, Michael F Bender, Haotian Lei, et al.
Environmental Science & Technology|January 9, 2025
Understanding the Molecular Mechanisms of Pyrene in Governing the Critical Metabolic Circuits of <i>Alexandrium pacificum</i>Xue-Ling Huang, Zhen-Hao Xu, Jiang-Bing Qiu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2018
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome EditingKanut Laoharawee, Russell C DeKelver, Kelly M Podetz-Pedersen, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.
The Journal of Biological Chemistry|August 30, 2021
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicityAdam S Olia, Yaroslav Tsybovsky, Steven J Chen, et al.
Pathogens & Immunity|January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype BM Gordon Joyce, Amy Bao, Man Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2018
ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler SyndromeLi Ou, Russell C DeKelver, Michelle Rohde, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Vaccines|January 22, 2024
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Plos Pathogens|September 22, 2023
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirusLi Ou, Steven J Chen, I-Ting Teng, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Structure (London, England : 1993)|March 17, 2023
Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitopePrabhanshu Tripathi, Michael F Bender, Haotian Lei, et al.
Environmental Science & Technology|January 9, 2025
Understanding the Molecular Mechanisms of Pyrene in Governing the Critical Metabolic Circuits of <i>Alexandrium pacificum</i>Xue-Ling Huang, Zhen-Hao Xu, Jiang-Bing Qiu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2018
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome EditingKanut Laoharawee, Russell C DeKelver, Kelly M Podetz-Pedersen, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.
The Journal of Biological Chemistry|August 30, 2021
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicityAdam S Olia, Yaroslav Tsybovsky, Steven J Chen, et al.
Pathogens & Immunity|January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype BM Gordon Joyce, Amy Bao, Man Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2018
ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler SyndromeLi Ou, Russell C DeKelver, Michelle Rohde, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Vaccines|January 22, 2024
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Plos Pathogens|September 22, 2023
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirusLi Ou, Steven J Chen, I-Ting Teng, et al.
Pageof 17